HCM Stock Summary and Trading Ideas (Hutchmed (China) Limited - American Depositary Shares | NASDAQ:HCM)

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Hutchmed (China) Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol HCM.

As of September 18, 2026, HCM stock price declined to $13.67 with 13,795 million shares trading.

HCM has a beta of 1.31, meaning it tends to be more sensitive to market movements. HCM has a correlation of 0.17 to the broad based SPY ETF.

HCM has a market cap of $2.38 billion. This is considered a Mid Cap stock.

In the last 3 years, HCM traded as high as $21.92 and as low as $9.77.

The top ETF exchange traded funds that HCM belongs to (by Net Assets): SPDW, DFEM, DFAX, DFSE, EHLS.

HCM has underperformed the market in the last year with a price return of -21.8% while the SPY ETF gained +16.7%. However, in the short term, HCM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +35.1% vs +3.3% return in SPY. But in the last 2 weeks, HCM shares have been beat by the market, returning -3.1% compared to an SPY return of -1.5%.

HCM support price is $13.53 and resistance is $14.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCM shares will trade within this expected range on the day.